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Abstract 
Aims: 1. to investigate diagnostic and prognostic procedures routinely used by international 
professionals to assess children with disorders of consciousness (DoC); 2. to explore use and 
availability of internal and national guidelines for paediatric DoC; 3. to identify international 
differences in diagnostic/prognostic protocols. 
Methods: The International Brain Injury Association DoC Special Interest Group emailed a 
survey link to 43,469 professionals. The survey included questions on diagnostic/prognostic 
procedures and guidelines for children with DoC.  
Results: Data on 82 respondents [(50% physicians) primarily from Europe (43.9%) and 
North America (37.8%)] were analysed. Common diagnostic tools included the Glasgow 
Coma Scale for clinical assessment (94%), the Coma Recovery Scale-Revised for outcome 
measurement (57%), and cerebral MRI (94%). Clinical features used most frequently to 
inform prognosis varied with age. Few respondents used national (28%) admission protocols 
for children with DoC, and most were unaware of published national guidelines for 
diagnostic (72%) and prognostic (85%) procedures. Compared to North American 
respondents, more European respondents were physicians and used neurophysiological data 
for prognosis. 
Conclusions: This international survey provides useful information about diagnostic and 
prognostic procedures currently used for children with DoC and highlights the need for 
guidelines to promote best practices for diagnosis/prognosis in paediatric DoC. 
Keywords: Disorders of Consciousness; paediatric population; severe brain injury; diagnosis; 
prognosis; medical practice survey; questionnaire.  
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Introduction 
Prolonged disorders of consciousness (DoC) following traumatic or non-traumatic severe 
brain injury encompass clinical conditions characterized by preserved wakefulness and a 
complete loss of consciousness [vegetative state/unresponsive wakefulness syndrome 
(VS/UWS)] (1,2) or minimal and reproducible behavioural signs of  awareness of 
environment and self [minimally conscious state (MCS)].(3) While there is more than 25 
years of research focusing on better understanding these severely disabling clinical states, 
diagnostic assessment and prediction of outcome of patients with DoC remains 
challenging.(4–6) Distinguishing patients in VS/UWS from those in MCS and predicting 
outcome are crucial for planning rehabilitation and apprising caregivers about ongoing 
recovery and life expectancy.  
 
For children, diagnosis and prognosis are even more challenging. Accurate assessment of 
children with DoC is particularly difficult given the rapidly developing skills during early 
childhood.(7) Clinical outcomes of children with DoC are not yet well-defined, since only a 
few cohort studies have addressed this issue.(8–11) Studies investigating diagnosis and 
prognosis of children with DoC have employed measures validated in adults(9–11) or 
included both children and adults.(11)  Given this paucity of research, there are no evidence-
based guidelines for clinical assessment and prognosis of children with DoC, as reported in 
the recent American care recommendations for patients with prolonged DoC.(12) 
 
The IBIA (International Brain Injury Association) DoC-Special Interest Group (DoC-SIG) 
developed and disseminated a survey for healthcare providers to explore which specific 
diagnostic protocols and prognostic indices are routinely adopted in care pathways for 
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children with DoC, if national or regional guidelines exist for diagnostic and prognostic 
procedures for children with DoC, and whether routine care or protocols differ by countries.  
 
Methods 
Survey questionnaire   
The survey consisted of 34 questions. Questions focused on diagnostic tools and prognostic 
indices routinely used in care and management of paediatric patients with DoC by 
professionals within each of the respondents’ facilities. Items were selected by four IBIA 
DoC-SIG members (E.M., B.S., A.E, C.S.) from current literature on clinical and 
instrumental measures for diagnosis and prognosis of patients with DoC.(4,13,14)  
 
Questions about respondents’ profession, country, institutional setting (i.e. post-acute 
rehabilitation, chronic facilities or nursing home), and age of admitted patients were included 
in the first section of the survey.   
 
Diagnostic and outcome measures. Respondents were asked to indicate tools routinely used 
by professionals at their institutions by choosing among: 1. neurobehavioral assessment 
measures [Glasgow Coma Scale (GCS),(15) Rappaport Coma Near Coma Scale (CNCS),(16) 
Levels of Cognitive Functioning Scale (LCFS),(17) Coma Recovery Scale Revised (CRS-
R),(18) and Western Neurosensory Stimulation Profile (WNSSP)(19)]; 2. neurobehavioral 
outcome measures [CNCS, LCFS, CRS-R, WNSSP, Disability Rating Scale (DRS),(20) 
Glasgow Outcome Scale-Extended (GOSE-E),(21,22) Glasgow Outcome Scale Extended-
Paediatrics (GOS-E Peds)(23)]; 3. neurophysiological measures [electroencephalography, 
brain stem auditory evoked potentials, visual evoked potentials, somatosensory evoked 
potentials, and event related potentials](24,25); 4. neuroimaging tools [computerized axial 
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tomography (CT), magnetic resonance imaging (MRI), positron emission tomography, and 
functional MRI (fMRI)].(26) For each tool, respondents were asked to indicate which 
measure they used for individuals of various age ranges: 0-< 6 months, 6 months–<3 years, 
3–7 years, 8-< 12 years, 13–<18 years.   
 
Prognostic indicators. Questions about prognostic indicators included demographic and 
medical history (age, aetiology, previous brain injury and premorbid clinical conditions), 
clinical features (diagnosis of VS/UWS versus MCS, pupillary reflex, visual fixation, visual 
pursuit/tracking, spontaneous motility, and time to follow commands) and clinical 
phenomena (pathological postures, dysautonomias/ paroxysmal sympathetic hyperactivity, 
psychomotor agitation/restlessness, primitive oral automatisms), medical  complications (e.g. 
recurrent infections/hyperthermia, assisted respiratory function, need for oxygen therapy, 
critical illness polyneuropathy/myopathy, heterotopic ossifications, epilepsy, severe 
spasticity), neurophysiological data (electroencephalography /polysomnography, brain stem 
auditory evoked potentials, visual evoked potentials, somatosensory evoked potentials, and 
event related potentials) and neuroimaging findings [CT, structural MRI, diffusion tensor 
imaging/tractography, fMRI/functional connectivity, positron emission tomography]. 
Respondents were asked to identify which pharmacological therapies possibly interfere with 
recovery of consciousness. Respondents were asked to indicate which clinical features were 
prognostic markers for various age ranges: 0-< 6 months, 6months-<3 years, 3-<12 years, 13-
<18 years. 
 
Guidelines.  Respondents were asked about the existence of published national/regional 
guidelines for diagnostic and prognostic procedures in children with DoC and if they follow 
any national or internal protocols for patients’ admission criteria.  A protocol was defined as 
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a guideline or set of guidelines issued by a committee, technical group, or work group on 
behalf of a national healthcare/government system (for national protocols) or on behalf of 
hospital/institution (for internal protocols).  The questionnaire is provided in the 
Supplementary Document.  
 
Survey dissemination procedure 
The survey was loaded on SurveyMonkey platform (https://www.surveymonkey.com). 
Invitation to participate were sent by e-mail to 43,469 individuals including IBIA or  
International Paediatric Brain Injury Society members, conference attendees, and others 
interested in learning about IBIA or IPBIS. Invitations were sent 3 times (initial invitation, 
reminders 15 days and 30 days later).  A total of 9,651emails were opened and 416 emails 
were not deliverable. Inclusion criteria for participation were a health professional or 
researcher working with children (0 to <18 years) with DoC and currently working in a centre 
admitting paediatric patients with DoC. No minimal period of experience was required. The 
survey was available online from 4/12/17 to 5/20/17, took 15-20 minutes to complete, and 
had to be completed in one session, as respondents could not edit responses after exiting the 
questionnaire. It was possible to skip questions. 
 
Data analysis 
Responses and omissions were calculated for each question. Because data were not missing 
completely at random, missing data were dealt with by item-level Multiple Imputation (MI), 
a “gold standard” method in treatment of data missing at random(27–30) (Little’s MCAR 
test, p<0.001). Responses towards the end of the questionnaire were most likely to be 
missing. For diagnostic measures and prognostic indicators, independent sample t-tests were 
used to compare means of those with and without missing data. Listwise deletion, pairwise 
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processing, and MI was applied to diagnostic and prognostic indicators. Further data 
normalization was performed based on respondents’ report of age ranges admitted to their 
facilities. Missing variable were imputed and adjusted for corresponding proportions of 
admission for each age range. We imputed 5, 10 and 50 datasets, conducted analyses on each 
imputed set, and pooled results. Multiple imputation with 50 datasets was chosen for 
reporting results. Demographics and use of diagnostic and prognostic tools were compared 
between respondents in different continents through 2 tests. 
 
Results 
Demographics 
Eighty-seven questionnaires were submitted. Five were excluded [2 respondents did not 
identify as health professionals or researcher (1=no response anonymous; 1=brain injury 
survivor), 3 did not admit children to their facilities]. Eighty-two surveys from 78 different 
medical centres were included (Figure 1).  
 
Most were medical doctors (50.0%) followed by psychologists (18.3%). Most were in Europe 
(43.9%) and North America (37.8%), whereas few were in other continents (e.g., Asia=7.3%, 
Africa=2.4%). Almost all respondents worked in facilities that admitted children between 3-
12 years of age (90.0%) and 13-17 years of age (92.5%). Less admitted those between 6 
months-3 years of age (73.8%) and <6 months of age (56.3%). Over half worked in facilities 
that also admitted individuals >18 years of age.  The respondents in Europe included more 
medical doctors (p=0.009; North America=33.3%; Europe=59.5%; for valid responses). More 
respondents in North America admitted 18-20 years olds (p=0.035; North America=78.8%; 
Europe=54.1%). (Table 1). 
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Over half worked in an intensive specialized rehabilitation facility for post-acute patients 
with DoC and one-third in a specialized rehabilitation setting for patients with chronic DoC. 
More than a quarter worked in community centres, private rehabilitation practices and 
hospitals for acute patients. A minority indicated working in more than one setting. (Table 2) 
 
Diagnostic and outcomes measures 
Neurobehavioral tools.  The GCS was employed most for clinical assessment of paediatric 
DoC followed by the CRS-R. (Table 3)    
 
The CRS-R was used most for outcome assessment overall and in children >3 years of age.  
For children <3 years of age, the GOS-E Peds was used most frequently. (Table 4) 
 
Neuroimaging and neurophysiological tools. Of neuroimaging tools, cerebral MRI was used 
routinely by most; CT scans were also used by three-quarters. Of neurophysiological tools, 
electroencephalography was used routinely for diagnosis more than other tools. (Table 5)   
 
Prognostic indicators 
Two thirds (66.3%) reported using prognostic indicators to plan rehabilitation treatment or to 
provide prognostic information to family caregivers in the clinical practice.  
 
Patient Characteristics. Aetiology of DoC was used most to inform prognosis (62.7%), 
followed by age (58.1%), premorbid clinical comorbidities (54.0%), and previous brain 
injury (52.0%). One third (33.2%) reported not using any patient characteristics to inform 
prognosis.  
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Clinical features and complications. Clinical features used to inform prognosis varied with 
age. Visual pursuit was reported most frequently as a prognostic marker for children <3 
years, whereas clinical diagnosis (VS/UWS versus MCS) was considered most informative in 
older children and adolescents. (Table 6)  
 
Clinical complications, including epilepsy, intractable severe spasticity, and neurosurgical 
sequelae (absence of cranioplasty or presence of hydrocephalus) were thought to be relevant 
for prognosis for more than three quarters of respondents, whereas need for oxygen therapy 
and the presence of heterotopic ossifications were used by less than half. (Table 7) 
 
Neurophysiological and neuroimaging tools. Most respondents used structural imaging 
findings (82.4%), followed by diffusion tensor imaging/tractography (30.8%) and 
fMRI/functional connectivity (22.8%) (for prognosis.  When considering neurophysiological 
data, 51.9% reported routinely using standard electroencephalographic background activity 
for prognosis. Other neurophysiological measures were reported to be used routinely less 
frequently [presence of N20 on somatosensory evoked potentials (29.9%), polysomnography 
over 24 hours/Sleep Patterns for Paediatric Unresponsive Wakefulness Syndrome (29.8%) 
and presence of late event related potentials (25.1%)]. A minority reported not using 
neuroimaging (17.1%) or neurophysiological data (36.8%) to inform prognosis. 
 
Pharmacological therapies. Most indicated that certain medications interfered with recovery 
[sedatives (e.g. benzodiazepines) (85.9%), anti-epileptic (74.6%), anti-spasticity (50.9%), and 
GABAergic (45.3%)]. 
 
Guidelines 
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Few respondents endorsed following national protocols for admission criteria for children 
with DoC, although over half reported following institutional protocols for admission.  Of 
those who followed national or internal protocols, many indicated that the protocols were 
originally developed for adults and adapted for children. Respondents who reported following 
national protocols for admission criteria specified several sources (e.g., Aspen workgroup on 
MCS, Multi-Society Task Force on PVS, document issued by Italian Ministry of Health in 
2005, Proceedings of consensus conference on Rehabilitation of TBI in 2000, regional 
documents, etc.)  Few reported knowledge of published national guidelines for diagnostic or 
prognostic procedures.  Of those, one indicated that there were clinical practice guidelines for 
acute DoC for children and another noted the existence of paediatric trauma literature; none 
identified specific publications. (Figure 2). 
 
Practice differences between Europe and North America 
Among neurobehavioral tools routinely adopted for clinical assessment and outcome, 
respondents reported using the WNSSP more frequently in North America (p=0.030 for 
assessment and outcome; North America=28.6%; Europe=4.0%). Use of other 
neurobehavioral measures did not differ between continents. Respondents in Europe reported 
routinely using neurophysiological tools more than those in North America [Brainstem 
auditory evoked potentials (p=0.018; North America=7.1%; Europe=44.0%), visual evoked 
potentials (p=0.038; North America=14.3%; Europe=48.2%) and somatosensory evoked 
potentials (p=0.022; North America=14.3%; Europe=52.1%)], and cerebral MRI (p=0.030; 
North America=57.1%; Europe=88.0%). Among patients’ characteristics, age (p=0.038; 
North America=85.7%; Europe=52.0%) and previous brain injury (p=0.039; North 
America=78.6%; Europe=43.8%) were more frequently considered for prognosis in North 
America.  
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Discussion 
This is the first international survey exploring use of diagnostic tools and prognostic indices 
for routine management of children with DoC.  Overall, respondents reported that commonly 
used diagnostic tools included GCS, CRS-R, MRI, and electroencephalography. Among 
clinical scales, the GCS was employed most for behavioural assessment of paediatric DoC. 
Frequently used neurobehavioral outcome measures varied by age, with the GOS-E Peds 
used for children <3 years and CRS-R for older children. Common prognostic indices 
included structural imaging and patient characteristics. Clinical features used most frequently 
to inform prognosis varied with age [visual pursuit for children <3 years, VS/UWS versus 
MCS for older children]. Few followed national protocols when admitting children with DoC 
and most were unaware of published national guidelines for diagnostic/prognostic 
procedures. Compared to North America, more respondents in Europe were physicians and 
used neurophysiological data for prognosis. 
 
The finding that GCS was the neurobehavioral measure most frequently used for clinical 
assessment of children with DoC is surprising given the limitations of the GCS in detecting 
signs of consciousness in adults with DoC.(31,32) While CRS-R is thought to be the gold 
standard for detecting level of consciousness in adults,(33) no study to date has examined 
reliability and validity of the CRS-R in children. Additionally, some items of the CRS-R may 
be unsuitable for young children due to reliance on language for many items. Also, the CRS-
R requires training that paediatric providers may not routinely obtain, while the GCS is a 
simple measure and familiar to most professionals, especially physicians.    
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The CRS-R was reported to be used most frequently as an outcome measure for children >3 
years of age; however, the GOS-E Peds is used most frequently for children aged <3 years. 
While the CRS-R has not been well studied in children and may not be appropriate in young 
children, the GOS-E Peds, a modification of the GOS-E for adults, was developed 
specifically for children.  There are also several studies examining the GOS-E in children 
with traumatic brain injury.(8,23,34) 
 
Neuroimaging and neurophysiological tools frequently used for diagnosis included MRI and 
CT scans and electroencephalography.  Responses are consistent with the literature showing 
that CT and MRI are useful to quantify structural brain disruption post-injury in children,(35) 
whereas electroencephalography detects factors potentially influencing clinical assessment 
(e.g. epileptiform abnormalities or non-convulsive epilepticus status) or complements the 
diagnostic process.(36,37) In adults, electroencephalography has proved useful for 
disentangling VS/UWS from MCS patients, since a worse background activity and lack of 
any electroencephalographic reactivity might characterize VS/UWS, whereas a better 
electroencephalographic background organization can identify patients with higher level of 
consciousness.(38) Recent studies have examined these methods in small cohorts of children 
with DoC,(25,26,39) exploring sub-tentorial diffusion tensor imaging measures as diagnostic 
biomarkers and electroencephalographic sleep/wake modulation as a prognostic biomarker. 
While advanced neuroimaging and neurophysiological techniques, such as event related 
potentials, visual evoked potentials and fMRI can supplement clinical evaluation, availability, 
methodological constraints and challenges in data interpretation might limit their use in 
clinical routine of patients with DoC.(40) 
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Outcome from DoC is difficult to predict in children and adults; however, similar to adults, 
levels of consciousness (MCS versus VS/UWS) have been associated with 
outcome.(10,11,41) Consistent with this literature, most respondents indicated using levels of 
consciousness as a prognostic marker for older children. Interestingly, for children <3 years 
of age, visual pursuit was thought to be most useful prognostic marker. Providers may 
identify visual pursuit as relevant for the youngest children because visual pursuit develops 
early in life and is typically present to some degree at birth. In adults in VS, prognostic utility 
of  visual pursuit is unclear.(42,43) To date, no study has examined the prognostic utility of 
visual pursuit in children with DoC. 
 
Many respondents identified aetiology of DoC and age as prognostic markers.  Similar to 
adults,(1,38) there is strong evidence that traumatic and non-traumatic aetiologies have very 
different outcomes in children.(1,11)  The role of age in considering prognosis after brain 
injury is debated. While there is growing evidence that younger children with diffuse brain 
injury have worse outcomes,(44–46) results are heavily biased by differences in common 
aetiologies of brain injury at different ages and the ongoing development of functional 
milestones (such as walking and talking) at young ages.(47,48)  
 
Medical complications including neurosurgical procedures, epilepsy, and intractable severe 
spasticity were used to inform prognosis. Consistent with the literature, epilepsy and its 
treatment were thought to interfere with recovery of consciousness.(36)  Spasticity is 
common in individuals with DoC(49) and respondents indicated that both severe spasticity 
and medications used to treat spasticity interfered with recovery.  While oral medication may 
interfere with arousal and responsiveness, the use of intrathecal baclofen (instead of 
potentially sedating oral medications) for spasticity has been associated with improvements 
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in adults with disorders of consciousness(50) suggesting that treating spasticity without 
increasing sedation may promote recovery of consciousness (or allow for more accurate 
assessment of signs of consciousness).  
 
Other prognostic markers commonly endorsed included structural MRI and diffusion tensor 
imaging, which is especially useful in detecting diffuse axonal injury.(26),(35)  Fewer 
professionals employed cerebral fMRI, which is typically used for research purposes. Despite 
providing information about cerebral blood flow and oxygen use, positron emission 
tomography is seldom used, probably due to higher invasiveness and because paediatric 
normative data have been made available only recently.(51,52) Many of the less commonly 
used neurophysiological and neuroimaging techniques were not necessarily available in 
facilities, since they are expensive, experimental, and require high levels of specialized 
expertise. 
 
Finally, the present study demonstrated that guidelines and recommendations for admission 
to institutions are lacking.  A few respondents reported the existence of national guidelines 
for admission and specified documents created primarily for adults (such as the original 
position papers on PVS and MCS).(1,3)  Given the paucity of national guidelines, it is not 
surprising that over half reported using internal guidelines for admission. None of these 
guidelines appeared to have been distributed outside the internal hospital system.  
Respondents also reported no clearly identifiable published guidelines for diagnosis and 
prognosis. While a few respondents indicated the existence of published guidelines for 
diagnosis or prognosis, no respondent identified a specific published document. The lack of 
reported published guidelines for diagnosis and prognosis is consistent with our review of the 
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literature; specifically, we found no published guidelines for diagnosis or prognosis in 
children with DoC. 
 
Study limitations 
Limitations include the small number of respondents out of a large number of individuals  
invited to participate.  While the low response ratemay limit generalizability, it is likely that 
the survey was not relevant to many of the individuals who received the email invitation 
including those who do not treat patients, do not treat patients with DOC, or do not work with 
children. Additionally, while 80% of respondents were providing care in Europe or North 
America, practice differences are difficult to interpret given differences in demographics 
between these two regions.  The preponderance of respondents from Europe/North America 
could highlight the lack of specialized units in for children with DoC in other regions of the 
world. Moreover, the survey was only available in English; we did not solicit practices and 
guidelines available to non-English speaking professionals. Lastly, due to missing data, we 
needed to apply multiple imputations, which may be imprecise.  
 
 
Conclusions 
This international survey provided useful information about diagnostic procedures and 
prognostic indices routinely used by professional working on care pathways for children with 
DoC. Results highlight the absence of available diagnostic tools and prognostic procedures 
specifically for this population.  Given limited research to guide care pathways for children 
with DoC, a consensus conference of experts would be useful to examine extant literature, 
identify gaps and future directions, and develop initial guidelines of diagnosis and prognosis 
in children with DoC. 
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Table 1. Respondent characteristics 
 
Overall Sample  
n=82 
Europe 
n=37 
North America 
n=33 
 % of respondents  in each category  
Profession 100.0 100.0 100.0 
Medical doctor 50.0 59.5 33.3 
Researcher 8.5 10.8 6.1 
Physical Therapist 7.3 2.7 9.1 
Psychologist 18.3 13.5 24.2 
Nurse 2.4 0.0 6.1 
Speech-language therapist 6.1 8.1 3.0 
Social worker 0.0 0 0.0 
Occupational therapist 2.4 5.4 6.1 
Other 4.9 0 12.1 
Areas of the world 100.0   
Europe 43.9 100 - 
North America 37.8 - 100 
Asia 7.3 - - 
Australia 6.1 - - 
Africa 2.4 - - 
South America 2.4 - - 
Age of admittance* 100.0   
0 to < 6 months 56.3 54.0 54.5 
6 months to <3 years 73.8 70.3 69.7 
3 to <13 years 90.0 81.1 90.9 
13 to <18 years 92.5 86.5 90.9 
18 to 20 years 65.0 54.1 78.8 
 > 21 years 46.3 45.9 48.5 
*multiple or null answers were allowed. 
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Table 2. Institutional setting selected by respondents (n=82).   
Type of setting  Selected answer (n=82) % of Respondents 
Intensive specialized rehabilitative 
setting for post-acute DoC patients 
(n=45) 
     55.6 
Specialized rehabilitative setting for 
chronic DoC patients (n=27) 
     33.3 
Nursing home (n=2)      2.5 
Other (n=24)      28.4 
% of Respondents 38.3 16.0 14.8 2.5 28.4  
 
Note. In the questionnaire, multiple or null answers were allowed 
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Table 3. Neurobehavioral measures routinely adopted for clinical assessment of the individuals aged 0-17 years in DoC.  
 
 
GCS CNCS LCFS CRS-R WNSSP 
 
Valid 
percent [%] 
50 imputations 
percent [%] 
Valid 
percent [%] 
50 imputations 
percent [%] 
Valid 
percent [%] 
50 imputations 
percent [%] 
Valid 
percent 
50 imputations 
percent [%] 
Valid 
percent [%] 
50 imputations 
percent [%] 
Total pediatric 
population 99.9 94.1 32.4 39.5 56.8 58.8 78.4 75.1 18.9 26.1 
0 to < 6 months 47.1 58.7 3.6 35.8 14.6 36.5 14.6 39.9 3.6 31.0 
6 months to < 3 
years 63.6 64.7 19.4 35.2 27.6 43.5 30.4 41.8 5.6 25.0 
3 to < 7 years 65.8 64.4 18.1 31.9 36.3 43.8 45.3 49.9 15.9 27.5 
8 to < 12 years 65.8 63.1 20.4 31.7 38.6 46.6 49.9 52.2 13.6 25.6 
13 to < 18 years 81.6 74.3 24.2 34.7 44.1 48.0 61.7 62.0 13.2 26.5 
 
GCS=Glasgow Coma Scale; CNCS=Rappaport Coma / Near Coma Scale; LCFS=Levels of Cognitive Functioning Scale; CRS-R=Coma Recovery 
Scale – Revised; WNSSP=Western Neurosensory Stimulation Profile. 
 
Note. Multiple or null answers were allowed, also within each age range. Results are normalized (50 imputations percent) with respect to the 
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percentage of institutions’ admitting patients in each specific age range.  
 
The most frequently used outcome measure in each age group are marked in bold. 
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Table 4. Neurobehavioral measures routinely adopted as outcome measures for individuals 0-17 years in DoC.  
 
 
DRS GOS-E GOS-E Peds CNCS LCFS CRS-R WNSSP 
 
Valid 
percent 
[%] 
50 
imputations 
percent [%] 
Valid 
percent 
[%] 
50 
imputations 
percent [%] 
Valid 
percent 
[%] 
50 
imputations 
percent [%] 
Valid 
percent 
[%] 
50 
imputations 
percent [%] 
Valid 
percent 
[%] 
50 
imputations 
percent [%] 
Valid 
percent 
[%] 
50 
imputations 
percent [%] 
Valid 
percent 
[%] 
50 
imputations 
percent [%] 
Total 
pediatric 
population 27.0 33.9 37.8 42.8 45.9 49.5 24.3 32.6 51.3 54.3 54.0 56.9 18.9 26.2 
0 -< 6 
months 0.0 0.0 3.6 29.5 36.2 54.1 3.6 33.1 7.3 32.0 7.3 34.3 7.3 35.6 
6 months -
< 3 years 5.6 26.2 16.5 33.7 35.9 45.8 13.8 30.2 24.9 41.3 27.6 41.2 11.1 28.7 
3 -< 7 
years 9.1 24.0 15.9 29.6 31.8 41.1 13.6 27.7 31.8 40.2 34.0 41.9 13.6 29.1 
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8 -< 12 
years 11.3 24.0 15.9 29.6 29.4 38.7 13.6 26.0 34.0 42.9 34.0 42.0 13.6 26.4 
13 -< 18 
years 22.1 32.1 28.7 37.2 35.4 41.7 19.9 29.8 42.0 46.2 42.0 46.1 15.5 27.0 
 
 
Legend. Multiple or null answers were allowed, also within each age range. Results are normalized (50 imputations percent) with respect to the 
percentage of institutions admitting patients in each specific age range (see ‘Age at admittance’ at bottom of Table 1). Neonates: 0 -< 6 months; 
infants: 6 months -< 3 years; pre-school children: 3 -< 7 years; school children: 8 -< 12 years; adolescents: 13 -< 18 years. DRS=Disability Rating 
Scale; GOS-E=Glasgow Outcome Scale Extended; GOS-E Peds=paediatric adaptation of the Glasgow Outcome Scale Extended; CNCS=Rappaport 
Coma / Near Coma Scale; LCFS=Levels of Cognitive Functioning Scale; CRS-R=Coma Recovery Scale – Revised; WNSSP=Western 
Neurosensory Stimulation Profile. 
The most frequently used outcome measure in each age group are marked in bold. 
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Table 5. Neurophysiological measures and neuroimaging tools routinely adopted in the diagnostic procedure of individuals 0-17 years in DoC.  
 
 
Neurophysiology Neuroimaging 
EEG BAEP VEP ERP SEP CT MRI PET fMRI 
Vali
d 
perc
ent 
[%] 
50 
imput
ations 
perce
nt 
[%] 
Valid 
perce
nt 
[%] 
50 
impu
tation
s 
perce
nt 
[%] 
Valid 
percent 
[%] 
50 
impu
tation
s 
perce
nt 
[%] 
Valid 
perce
nt 
[%] 
50 
imput
ation
s 
perce
nt 
[%] 
Valid 
perce
nt [%] 
50 
impu
tation
s 
perce
nt 
[%] 
Valid 
percent 
[%] 
50 
imputat
ions 
percent 
[%] 
Valid 
perce
nt 
[%] 
50 
imput
ation
s 
perce
nt 
[%] 
Valid 
perce
nt [%] 
50 
imputa
tions 
percent 
[%] 
Valid 
percent 
[%] 
50 
imputati
ons 
percent 
[%] 
Total pediatric population 81.1 79.1 37.8 42.1 40.5 45.4 16.2 23.6 43.2 48.3 75.7 74.8 99.9 94.0 18.9 26.7 24.3 32.0 
0 -< 6 months 47.1 61.0 21.7 45.0 25.4 44.3 3.6 25.6 29.0 49.6 43.5 58.5 61.6 69.8 10.8 34.3 3.6 34.7 
6 months -< 3 years 52.6 57.2 19.4 34.9 24.9 38.5 2.7 19.4 24.9 37.5 47.0 55.5 66.4 68.9 8.3 28.8 2.7 27.3 
3 -< 7 years 49.9 51.7 20.4 31.3 22.7 34.3 4.6 23.0 24.9 23.1 45.3 47.8 63.4 61.1 9.1 24.5 6.8 22.6 
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8 -< 12 years 49.9 51.1 22.7 31.9 24.9 36.0 4.6 20.9 24.9 35.6 47.7 49.5 65.8 64.1 9.1 24.6 9.1 24.7 
13 -< 18 years 66.2 64.1 30.9 37.3 30.9 39.3 13.2 27.3 35.4 44.2 61.7 60.3 81.6 73.5 15.5 30.3 19.9 31.4 
 
Legend. Multiple or null answers were allowed, also within each age range. Results are normalized with respect to the percentage of institutions 
admitting patients in each specific age range (see ‘Age at admittance’ at bottom of Table 1). Neonates: 0 -< 6 months; infants: 6 months -< 3 years; 
pre-school children: 3 -< 7 years; school children: 8 -< 12 years; adolescents: 13 -< 18 years. EEG=electroencephalogram; BAEP=Brainstem 
Auditory Evoked Potential; VEP=Visual Evoked Potentials; ERP=Event Related Potentials (i.e. P300 and Mismatch Negativity); 
SEP=Somatosensory Evoked Potential; CT=Computerized Tomography; MRI=structural Magnetic Resonance Imaging; PET=Positron Emission 
Tomography; fMRI=functional Magnetic Resonance Imaging. The two most frequently used instrumental diagnostic tools in each age group are 
marked in bold. 
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Table 6. Clinical features used as prognostic markers for the individuals aged 0-17 in DoC.  
 
 
Clinical diagnosis 
of VS/UWS or 
MCS Pupillary reflex 
Optical fixation 
ability Visual pursuit 
Presence of 
spontaneous motility 
Time interval to follow 
commands 
 
Valid 
percent 
[%] 
50 
imputati
ons 
percent 
[%] 
Valid 
percent 
[%] 
50 
imputati
ons 
percent 
[%] 
Valid 
percent 
[%] 
50 
imputatio
ns percent 
[%] 
Valid 
percent 
[%] 
50 
imputatio
ns percent 
[%] 
Valid 
percent 
[%] 
50 
imputati
ons 
percent 
[%] 
Valid 
percent [%] 
50 imputations 
percent [%] 
Total pediatric population 63.2 63.6 48.2 52.8 45.1 50.6 60.2 60.5 54.2 55.9 60.2 60.5 
0 -< 6 months 16.2 43.4 36.4 57.1 28.2 51.2 40.3 59.6 40.3 58.5 24.2 49.1 
6 months -< 3 years 27.8 43.9 30.8 46.4 30.8 42.7 43.1 52.8 37.0 49.5 30.8 45.2 
3 -< 12 years 40.4 46.5 30.3 38.9 30.3 41.1 37.9 43.0 32.8 42.0 35.3 44.6 
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13 -< 18 years 51.6 52.2 39.4 45.1 34.4 43.7 44.2 47.2 39.4 45.4 49.2 50.2 
 
Legend. Multiple or null answers were allowed, also within each age range. 
 
Results are normalized with respect to the percentage of institutions admitting patients in each specific age range.  
 
The most frequently used clinical prognostic markers in each age group are marked in bold.  
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Table 7. Clinical phenomena and clinical complications used as prognostic markers in individuals 
aged 0-17 in DoC. 
 
Prognostic clinical phenomena or clinical complications. 
Valid 
percent 
[%] 
50 
imputations 
percent [%] 
Presence of pathological postures (decortication/ decerebration) 71.0 66.3 
Presence of vegetative dysautonomia/ Paroxysmal Sympathetic 
Hyperactivity 
61.3 59.2 
Presence of psychomotor agitation/ restlessness 64.5 61.6 
Presence of primitive oral automatisms (sucking, yawning, etc) 51.6 53.2 
Presence of recurrent infections/ hyperthermia 67.7 63.1 
Assisted respiratory function 64.5 61.2 
 Need of oxygen therapy 48.4 48.8 
Presence of critical illness: polyneuropathy and myopathy 54.8 53.7 
The presence of heterotopic ossifications 32.3 36.1 
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Presence of neurosurgical sequelae (absence of cranioplasty, 
hydrocephalus) 
80.6 73.1 
Presence of epilepsy 87.1 79.3 
Presence of intractable (severe) spasticity 87.1 78.7 
 
Note. Multiple or null answers were allowed.  
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Figure 1. Survey dissemination procedure and data collection 
 
Figure 2. Use of national or institutional protocols for admission and awareness of published 
national guidelines or recommendations about diagnostic or prognostic procedures for 
children in DoC 
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Figure	  2.	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  protocols
